A Case Study in Application of the Risk Knowledge Infinity Cycle

References

1. 1.↵
   International Conference for Harmonisation. Quality Guideline Q10: Pharmaceutical Quality System Q10. ICH: Geneva, 2008. https://database.ich.org/sites/default/files/Q10Guideline.pdf
2. 2.↵
   1. O’Donnell K.

   A Regulator’s Perspective on Quality Risk Management & Knowledge Management after 12 Years of QRM & KM—The Twin Enablers in ICH Q10. In PDA 2020 Europe Quality and Regulations Conference (Virtual); PDA 2020 Europe Quality and Regulations Conference (Virtual), 2020.
3. 3.↵
   International Conference for Harmonisation. Quality Guideline Q9: Pharmaceutical Quality System. ICH: Geneva, 2005. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/%5CnGuidelines/Quality/Q9/Step4/Q9_Guideline.pdf
4. 4.↵
   1. Calnan N.,
   2. Lipa M. J.,
   3. Kane P.,
   4. Menezes J. C.

   1. Calnan N.,
   2. Greene A.,
   3. Kane P. E.

   An Academic Perspective Knowledge Management: the Orphan Enabler—Enabling ICH Q10 Implementation. A Lifecycle Approach to Knowledge Excellence in the Biopharmaceutical Industry; Calnan N., Lipa M. J., Kane P., Menezes J. C., Eds.; Taylor & Francis: Boca Raton, FL, 2018; pp 133–151.
5. 5.↵
   1. Kane P. E.,
   2. Lipa M. J.,
   3. Greene A.,
   4. Calnan N. F.

   Knowledge Management Implementation: A Survey of the Biopharmaceutical Industry. ISPE Pharmaceutical Engineering 2020.
6. 6.↵
   ISPE. ISPE Good Practice Guide: Knowledge Management in the Pharmaceutical Industry; ISPE: Tampa, FL, 2021.
7. 7.↵
   International Conference for Harmonisation. Final Concept Paper ICH Q9(R1): Quality Risk Management. ICH: Geneva, 2020.
8. 8.↵
   International Conference for Harmonisation. Quality Guideline Q9(R1): Pharmaceutical Quality System. ICH: Geneva, 2023. https://database.ich.org/sites/default/files/ICH_Q9%28R1%29_Guideline_Step4_2023_0126_0.pdf
9. 9.↵
   1. Lipa M. J.,
   2. O’Donnell K.,
   3. Greene A.

   A Survey Report on the Current State of Quality Risk Management (QRM) and Knowledge Management (KM) Integration. Level 3 2021, 15 (3).
10. 10.↵
    1. Lipa M. J.,
    2. O’Donnell K.,
    3. Greene A

    , Technological University Dublin. Managing Knowledge and Risk - A Literature Review on the Interdependency of QRM and KM as ICH Q10 Enablers. J. Validation Technol. 2020, 26 (4),
11. 11.↵
    1. Lipa M. J.,
    2. O’Donnell K.,
    3. Greene A.

    Knowledge as the Currency of Managing Risk: A Novel Framework to Unite Quality Risk Management and Knowledge Management. Level 3 2020, 15 (2).
12. 12.↵
    International Conference on Harmonisation. ICH Q9(R1) Training Materials; ICH: Geneva, 2023. https://database.ich.org/sites/default/files/ICH_Q9%28R1%29EWG_Training_Materials_2023_1005.zip
13. 13.↵
    1. McEwen S.

    Out of Specification Test Results Remediation Case Studies. In PDA/FDA Joint Regulatory Conference; PDA: Washington DC, 2019.
14. 14.↵
    1. Lipa M. J.,
    2. Mulholland V.

    Exploring the Risk Knowledge Infinity Cycle (RKI Cycle) Across the Product Lifecycle. ISPE Webinar. https://ispe.org/webinars/exploring-risk-knowledge-infinity-cycle-rki-cycle-across-product-lifecycle (accessed April 29, 2021).
15. 15.↵
    1. Lipa M. J.

    Building a Solid Foundation for a Pharmaceutical Quality System—Presenting QRM and KM as United Enablers. Bioprocess Int. 2022, 20 (9).
16. 16.↵
    1. Calnan N.,
    2. Lipa M. J.,
    3. Kane P.,
    4. Menezes J. C.

    1. Kane P. E.,
    2. Lipa M. J.

    The House of Knowledge Excellence—A Framework for Success. In A Lifecycle Approach to Knowledge Excellence in the Biopharmaceutical Industry; Calnan N., Lipa M. J., Kane P., Menezes J. C., Eds.; Taylor & Francis: Boca Raton, FL, 2018; pp 181–224.
17. 17.↵
    1. Beardsley S. C.,
    2. Johnson B. C.,
    3. Manyika J. M.

    Competitive Advantage from Better Interactions. McKinsey Quarterly 2006, (2), 52–63.
18. 18.↵
    APQC. Introduction to Knowledge Management (KM). 2018. https://www.apqc.org/resource-library/resource-listing/introduction-knowledge-management-km-essentials-0.
19. 19.↵
    1. Lipa M. J.,
    2. Mulholland V.,
    3. Greene A.

    Integrating Knowledge Management and Quality Risk Management. ISPE Pharmaceutical Engineering 2022, 42 (4), 14–23.

    OpenUrl